Q4287 identifies Dermabind DL, while Q4284 identifies Dermabind SL. Select the code that matches the variant supplied.
On this page
CMS RVU26D · Effective 2026-10-01
Q4284 Wound product Medicare reimbursement rates in Oklahoma
Reports Dermabind SL supplied for wound treatment, measured by the number of square centimeters and paired with the applicable primary application procedure. Compare Q4284 office and facility rates across CMS payment localities in Oklahoma.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4284 in Oklahoma?
Oklahoma has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$113.64
1 of 1 localities have a supported rate.
Payment area: Oklahoma
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care product
About Q4284: Dermabind SL wound product
Reports Dermabind SL supplied for wound treatment, measured by the number of square centimeters and paired with the applicable primary application procedure.
Q4284 identifies Dermabind SL supplied for application to a wound as a skin-substitute wound product. Wound-care clinicians may use it in settings such as outpatient wound clinics, physician offices, and hospital outpatient departments. The code represents the product quantity, not the clinical work of preparing the wound or applying the product; those services are represented by the appropriate primary procedure.
Report units based on the square centimeters of Dermabind SL supplied, and document the product variant, wound site, treated area, and associated application procedure. This is an add-on code: it must be billed with a primary procedure, and payment falls within that procedure's global period. CMS classifies Q4284 as technical-component-only, with a separate code covering interpretation.
CMS billing rules for Q4284
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4284 compared with similar codes
Office rates for Oklahoma, from the same CMS release.
Q4288 identifies Dermabind CH, not the SL variant represented by Q4284. Verify the product documentation before choosing between them.
Compare Q4284 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Oklahoma →
Office / nonfacility
$113.64
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4284 in Oklahoma.
PPRRVU2026_Oct_nonQPP.csv
18,371
- Code
- Q4284
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
86
- Locality
- Oklahoma
- Physician work
- 1.000
- Practice expense
- 0.893
- Malpractice
- 0.777
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.893 | 3.4023 |
| Malpractice | 0.00 | × 0.777 | 0.0000 |
| Total RVUs | 3.4023 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Oklahoma$113.64
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.893 |
| Malpractice | 0 | 0.777 |
(0 × 1 + 3.81 × 0.893 + 0 × 0.777) × $33.4009 = $113.64
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4284 billing questions
How is Q4284 distinguished from Q4287 and Q4288?
Q4284 identifies Dermabind SL. Q4287 and Q4288 identify Dermabind DL and Dermabind CH, respectively; use the code matching the product variant documented as supplied.
Can Q4284 be reported without a primary procedure?
No. It is an add-on code and must be billed with the applicable primary wound-application procedure.
How many units should be reported?
Report the number of square centimeters of Dermabind SL supplied. The record should support the product variant and measured area.
Does Q4284 have a separate global period?
No. Payment for this add-on falls within the global period of the primary procedure it accompanies.
What documentation supports Q4284?
Document Dermabind SL as the product supplied, the wound site and treated area, and the primary application procedure reported with it.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
